Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei

Journal of Clinical Microbiology

Volumn 47, Issue 5, 2009, Pages 1556-1558

  Sam, I Ching ^a   Kah, Heng See ^a   Puthucheary, Savithri D ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFTAZIDIME; CYSTEINE; TYROSINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CASE REPORT; CONTROLLED STUDY; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; MALE; MELIOIDOSIS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

AMINO ACID SUBSTITUTION; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; DNA, BACTERIAL; HUMANS; MALE; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

BURKHOLDERIA PSEUDOMALLEI;

EID: 66149139711     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01657-08     Document Type: Article

References (22)

1. Ambler, R. P., A. F. W. Coulson, J. M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-270.
2. Chantratita, N., V. Wuthiekanun, K. Boonbumrung, R. Tiyawisutsri, M. Vesaratchavest, D. Limmathurotsakul, W. Chierakul, S. Wongratanacheewin, S. Pukritiyakamee, N. J. White, N. P. J. Day, and S. J. Peacock. 2007. Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei. J. Bacteriol. 189:807-817. (Pubitemid 46183855)
3. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
4. Dance, D. A., V. Wuthiekanun, W. Chaowagul, Y. Suputtamongkol, and N. J. White. 1991. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J. Antimicrob. Chemother. 28:321-324.
5. Dance, D. A., V. Wuthiekanun, W. Chaowagul, and N. J. White. 1989. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J. Antimicrob. Chemother. 24:295-309.
6. Haase, A., A. Melder, H. Smith-Vaughan, D. Kemp, and B. Currie. 1995. RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis. Epidemiol. Infect. 115:115-121.
7. Häussler, S., M. Rohde, and I. Steinmetz. 1999. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med. Microbiol. Immunol. 188:91-97.
8. Helfand, M. S., A. M. Hujer, F. D. Sönnichsen, and R. A. Bonomo. 2002. Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV β-lactamase. J. Biol. Chem. 277:47719-47729.
9. Ho, P. L., T. K. Cheung, W. C. Yam, and K. Y. Yuen. 2002. Characterization of a laboratory-generated variant of BPS beta-lactamase from Burkholderia pseudomallei that hydrolyses ceftazidime. J. Antimicrob. Chemother. 50:723-726. (Pubitemid 35331691)
10. Holden, M. T., R. W. Titball, S. J. Peacock, A. M. Cerdeno-Tarraga, T. Atkins, L. C. Crossman, T. Pitt, C. Churcher, K. Mungall, S. D. Bentley, M. Sebaihia, N. R. Thomson, N. Bason, I. R. Beacham, K. Brooks, K. A. Brown, N. F. Brown, G. L. Challis, I. Cherevach, T. Chillingworth, A. Cronin, B. Crossett, P. Davis, D. DeShazer, T. Feltwell, A. Fraser, Z. Hance, H. Hauser, S. Holroyd, K. Jagels, K. E. Keith, M. Maddison, S. Moule, C. Price, M. A. Quail, E. Rabbinowitsch, K. Rutherford, M. Sanders, M. Simmonds, S. Songsivilai, K. Stevens, S. Tumapa, M. Vesaratchavest, S. Whitehead, C. Yeats, B. G. Barrell, P. C. Oyston, and J. Parkhill. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. USA 101:14240-14245.
11. Jenney, A. W. J., G. Lum, D. A. Fisher, and B. J. Currie. 2001. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int. J. Antimicrob. Agents 17:109-113.
12. Keith, K. E., P. C. Oyston, B. Crossett, N. F. Fairweather, R. W. Titball, T. R. Walsh, and K. A. Brown. 2005. Functional characterization of OXA-57, a class D β-lactamase from Burkholderia pseudomallei. Antimicrob. Agents Chemother. 49:1639-1641.
13. Kumar, A., M. Mayo, L. A. Trunck, A. C. Cheng, B. J. Currie, and H. P. Schweizer. 2008. Expression of resistance-nodulation-cell division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from northern Australia. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S145-S151.
14. Limmathurotsakul, D., V. Wuthiekanun, N. Chantratita, G. Wongsuvan, A. Thanwisai, M. Biaklang, S. Tumapa, S. Lee, N. P. J. Day, and S. J. Peacock. 2007. Simultaneous infection with more than one strain of Burkholderia pseudomallei is uncommon in human melioidosis. J. Clin. Microbiol. 45: 3830-3832. (Pubitemid 350156898)
15. Maharjan, B., N. Chantratita, M. Vesaratchavest, A. Cheng, V. Wuthiekanun, W. Chierakul, W. Chaowagul, N. P. J. Day, and S. J. Peacock. 2005. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J. Clin. Microbiol. 43:6032-6034. (Pubitemid 43100656)
16. Niumsup, P. R., A. Tansawai, and V. Wuthiekanun. 2007. Resistance to ceftazidime or clavulanic acid inhibition in Burkholderia pseudomallei does not result from mutation within the β-lactamase genes, abstr. MOP017. Abstr. 5th World Melioidosis Congress.
17. Niumsup, P., and V. Wuthiekanun. 2002. Cloning of the class D-β-lactamase gene from Burkholderia pseudomallei and studies in its expression in ceftazidime-susceptible and -resistant strains. J. Antimicrob. Chemother. 50:445-455. (Pubitemid 35214782)
18. Pitt, T. L., S. Trakulsomboon, and D. A. B. Dance. 2007. Recurrent melioidosis: possible role of infection with multiple strains of Burkholderia pseudomallei. J. Clin. Microbiol. 45:680-681.
19. Ribot, E. M., M. A. Fair, R. Gautom, D. N. Cameron, S. B. Hunter, B. Swaminathan, and T. J. Barrett. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
20. Tan, A. L., and M. L. Tan. 2008. Melioidosis: antibiogram of cases in Singapore 1987-2007. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):S101-S102.
21. Tribuddharat, C., R. A. Moore, P. Baker, and D. E. Woods. 2003. Burkholderia pseudomallei class A β-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Antimicrob. Agents Chemother. 47:2082-2087. (Pubitemid 36753554)
22. Vadivelu, J., S. D. Puthucheary, B. S. Drasar, D. A. Dance, and T. L. Pitt. 1998. Stability of strain genotypes of Burkholderia pseudomallei from patients with single and recurrent episodes of melioidosis. Trop. Med. Int. Health 3:518-521. (Pubitemid 28373859)